Get started
Editas Medicine Inc.Editas Medicine Inc.Editas Medicine Inc.

Editas Medicine Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Forecast Seasonals

8EM trade ideas

ABC BullishPossible stop below C. B is 99.95. Long impulse wave up and has pulled back to the 0.786. This one can be very volatile and retests of C are common..and it may go lower than C so maybe set stop accordingly. Not a recommendation. There are no rising wedges in the yearly chart. Todays candle is a green engulfing candle. Some use the 5 crosing the 20 as a buy signal and the 5 has not crossed up and through the 20. Long term MAs are sloping up, the 50 is sloping down. NV and OBV are perking up. Long entry level is an at or above level.
NASDAQ:EDITLong
by lauralea
3
Editas Medicine (EDIT) Opinion...This chart is my second, and has to do with my second lovely stock, EDIT. It is a stock that seems to move in a stable chanel as we can see in the chart. We obviously see a support zone in ~56.00 that looks stable for now. I also believe this stock so much and we expect in early March the economic results of the company. I have multible buys (positions) for this stock opened from 63.00 to 56.00. I will keep them opened of couse but I do not know if i will add more positions but I will attempt to make a prediction and tell that, we will soon see 66.00 at least. I am totally sure that if today will see a green candle, the MACD and RSI indicators will surely show us the way...
NASDAQ:EDITLong
by kgeorgs13
3
EDIT - Add to watchlist - Bull FlagBig beautiful bull flag formation. Concerns? Divergence in MACD. We did get a nice bump in volume on that first bottom in the lower trendline, but then it flatlined after. This might take a little more time to form. Keep an eye on it. I like the fact RSI is forming a bottom. Whenever I see gaps in a flagpole I grow concerned about investors who desperately want to see the gap filled. Keeping this one on the backburner for now. Chart alone looks stupendous though. Friday's candle implies that buyers are coming back. Might just get the bump it needs on Tuesday/Wednesday.
NASDAQ:EDITLong
by SLOPolarBear
6
EDIT Genome Editing Long-Term SwingEDIT NASDAQ:EDIT is a genome editing company with treatments being developed for Leber congenital amaurosis**, Usher syndrome, neurological diseases, Sickle cell disease, beta-thalassemia, as well as cancer treatments through NK cells. The leber congenital amaurosis clinical trial is currently the furthest along but still in its earlier stages but has completed dosing all of its patients. The results of that clinical trial will be HUGE. That will set the blueprint for EDIT as a company. The same principles for that EDIT-101 clinical trial are being applied to multiple other medicines and can lay the blueprint for huge medical breakthroughs. ARK believes genome editing is the future of medicine and I agree. This 46% sell off since EDIT’s highs looks to be a strong bounce area. I grabbed a small starter position on Friday last week but will look to add to my position this week and add dips to $50. If we fail $50.48 HVN area I will use that as my stop. Chart: EDIT looks to be in a prime bounce zone right now and I will be looking for it to hold the HVN area ($57-$66) for some consolidation. Daily .618 fib retracement line has served as support multiple times and will want that to hold up this week. Need some volume to being accumulating on EDIT and close back over the $58 lvl.
NASDAQ:EDITLong
by DOpeTrades
1